miR-522調(diào)控人腦膠質(zhì)母細(xì)胞瘤細(xì)胞增殖的作用機(jī)制研究
發(fā)布時(shí)間:2021-06-23 16:42
研究背景大腦和脊髓膠質(zhì)細(xì)胞發(fā)生癌變,所產(chǎn)生的最常見的原發(fā)性腦部腫瘤即是膠質(zhì)瘤,它大概占到了人類腦部腫瘤的70%-80%。腦膠質(zhì)瘤包括少枝細(xì)胞瘤,混合膠質(zhì)母細(xì)胞瘤,室管膜瘤和星形細(xì)胞瘤。膠質(zhì)母細(xì)胞瘤(glioblastoma, GBM),作為一類原發(fā)性神經(jīng)系統(tǒng)腫瘤,發(fā)病率高,惡性度極高,預(yù)后非常差,嚴(yán)重影響患者預(yù)后及生存質(zhì)量,給家庭和社會(huì)帶來(lái)沉重負(fù)擔(dān)。手術(shù)目的是盡可能最大限度地去除腫瘤,又盡可能的保留神經(jīng)功能。但是無(wú)法根本徹底清除微小病灶,這也是目前無(wú)法徹底治愈膠質(zhì)母細(xì)胞瘤,避免復(fù)發(fā)的原因所在;颊咦罱K死亡的根本原因多半由于膠質(zhì)母細(xì)胞瘤不斷地侵入和破壞周圍的腦組織,致使腦功能進(jìn)一步缺失,最終造成患者呼吸循環(huán)衰竭或者多臟器功能衰竭。所以,更深入地了解促進(jìn)膠質(zhì)母細(xì)胞瘤入侵的分子過(guò)程,進(jìn)而克服膠質(zhì)母細(xì)胞瘤細(xì)胞浸潤(rùn)周圍的正常腦組織,是接下來(lái)我們面臨的主要挑戰(zhàn)。然而,盡管手術(shù)-術(shù)后放療以及替莫唑胺聯(lián)用化療可以提高手術(shù)治療后的生存率,但是72%的患者仍然在手術(shù)后17個(gè)月內(nèi)會(huì)面臨腫瘤復(fù)發(fā),患者的五年存活率只有9.8%。鑒于膠質(zhì)母細(xì)胞瘤的極差的預(yù)后,研究者開展了很多工作來(lái)努力尋找可以對(duì)膠質(zhì)母細(xì)胞瘤進(jìn)行分...
【文章來(lái)源】:山東大學(xué)山東省 211工程院校 985工程院校 教育部直屬院校
【文章頁(yè)數(shù)】:115 頁(yè)
【學(xué)位級(jí)別】:博士
【部分圖文】:
圖2QPCR結(jié)果;miR-522在正常腦星形細(xì)胞(NHA巧日腦膠質(zhì)母細(xì)胞瘤腦細(xì)胞(LN18,??
15?-逗玄10?.?■??I??i:Ll??促進(jìn)GBM細(xì)胞的增殖。QPCR結(jié)果;miR-52pregulation?promotes?GBM?cell?prolifesion?levels?after?transfection?by?PCRean?of?three?independent?experiments?——-i??
成實(shí)驗(yàn);miR-522inimics轉(zhuǎn)染U87MG細(xì)胞,左色陽(yáng)性細(xì)胞克隆的量化統(tǒng)計(jì)圖片。??esentative?micrographs?(left)?a打d?quantificlet-stained?cell?colonies.?Each?bar?represendent?experiments.沖?<?0.05.??E?91?NC?■?miR-522??至?240r?.??NC?miR-522?2-i8〇,?j??■MBI-?I??■KSpo.巧?I??〇??
【參考文獻(xiàn)】:
期刊論文
[1]Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma[J]. Wen Wang, Lan-Juan Zhao, Hao Ren, Zhong-Tian Qi, Department of Microbiology, Shanghai Key Laboratory of Medical Biodefense, Second Military Medical University, Shanghai 200433, China Ye-Xiong Tan, Laboratory of Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200433, China. World Journal of Gastroenterology. 2012(38)
[2]PHLPP在上皮性卵巢癌中的表達(dá)及其臨床意義[J]. 廖琪,杜紹敏,李秀巖. 中國(guó)婦幼保健. 2010(32)
[3]惡性腫瘤轉(zhuǎn)移機(jī)制研究新進(jìn)展[J]. 左衍海,施鑫. 醫(yī)學(xué)研究生學(xué)報(bào). 2008(03)
本文編號(hào):3245296
【文章來(lái)源】:山東大學(xué)山東省 211工程院校 985工程院校 教育部直屬院校
【文章頁(yè)數(shù)】:115 頁(yè)
【學(xué)位級(jí)別】:博士
【部分圖文】:
圖2QPCR結(jié)果;miR-522在正常腦星形細(xì)胞(NHA巧日腦膠質(zhì)母細(xì)胞瘤腦細(xì)胞(LN18,??
15?-逗玄10?.?■??I??i:Ll??促進(jìn)GBM細(xì)胞的增殖。QPCR結(jié)果;miR-52pregulation?promotes?GBM?cell?prolifesion?levels?after?transfection?by?PCRean?of?three?independent?experiments?——-i??
成實(shí)驗(yàn);miR-522inimics轉(zhuǎn)染U87MG細(xì)胞,左色陽(yáng)性細(xì)胞克隆的量化統(tǒng)計(jì)圖片。??esentative?micrographs?(left)?a打d?quantificlet-stained?cell?colonies.?Each?bar?represendent?experiments.沖?<?0.05.??E?91?NC?■?miR-522??至?240r?.??NC?miR-522?2-i8〇,?j??■MBI-?I??■KSpo.巧?I??〇??
【參考文獻(xiàn)】:
期刊論文
[1]Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma[J]. Wen Wang, Lan-Juan Zhao, Hao Ren, Zhong-Tian Qi, Department of Microbiology, Shanghai Key Laboratory of Medical Biodefense, Second Military Medical University, Shanghai 200433, China Ye-Xiong Tan, Laboratory of Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200433, China. World Journal of Gastroenterology. 2012(38)
[2]PHLPP在上皮性卵巢癌中的表達(dá)及其臨床意義[J]. 廖琪,杜紹敏,李秀巖. 中國(guó)婦幼保健. 2010(32)
[3]惡性腫瘤轉(zhuǎn)移機(jī)制研究新進(jìn)展[J]. 左衍海,施鑫. 醫(yī)學(xué)研究生學(xué)報(bào). 2008(03)
本文編號(hào):3245296
本文鏈接:http://sikaile.net/yixuelunwen/shenjingyixue/3245296.html
最近更新
教材專著